Hjem
Dennis WT Nilsens bilde

Dennis WT Nilsen

Emeritus
  • E-postdennis.nilsen@uib.no
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) (2022). The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease. Thrombosis and Haemostasis. 12 sider.
  • Vis forfatter(e) (2022). Podocan and Adverse Clinical Outcome in Patients Admitted With Suspected Acute Coronary Syndromes. Frontiers in Cardiovascular Medicine. 1-9.
  • Vis forfatter(e) (2022). Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial. Journal of Internal Medicine. 637-647.
  • Vis forfatter(e) (2021). Serum levels of dihomo-gamma (γ)-linolenic acid (dgla) are inversely associated with linoleic acid and total death in elderly patients with a recent myocardial infarction. Nutrients. 1-13.
  • Vis forfatter(e) (2021). Incidence and risk factors for major bleeding among patients undergoing percutaneous coronary intervention: Findings from the Norwegian Coronary Stent Trial (NORSTENT). PLOS ONE.
  • Vis forfatter(e) (2021). Complement component 7 is associated with total- and cardiac death in chest-pain patients with suspected acute coronary syndrome. BMC Cardiovascular Disorders. 1-12.
  • Vis forfatter(e) (2021). Angiopoietin-2 and angiopoietin-like 4 protein provide prognostic information in patients with suspected acute coronary syndrome. Journal of Internal Medicine. 1-16.
  • Vis forfatter(e) (2021). Activated factor XI-antithrombin complex presenting as an independent predictor of 30-days mortality in out-of-hospital cardiac arrest patients. Thrombosis Research. 1-8.
  • Vis forfatter(e) (2020). Transsulfuration metabolites and the association with incident atrial fibrillation – An observational cohort study among Norwegian patients with stable angina pectoris. International Journal of Cardiology. 75-80.
  • Vis forfatter(e) (2020). N-terminal pro-B-type natriuretic peptide as a prognostic indicator for 30-day mortality following out-of-hospital cardiac arrest: A prospective observational study. BMC Cardiovascular Disorders. 1-10.
  • Vis forfatter(e) (2020). Lipid parameters and vitamin A modify cardiovascular risk prediction by plasma neopterin. Heart. 1073-1079.
  • Vis forfatter(e) (2020). Effects of n-3 fatty acid supplementations in elderly patients after myocardial infarction: A randomized controlled trial. Circulation. 528-539.
  • Vis forfatter(e) (2020). Circulating trimethyllysine and risk of acute myocardial infarction in patients with suspected stable coronary heart disease. Journal of Internal Medicine. 446-456.
  • Vis forfatter(e) (2019). Effects of the PAR-1 Antagonist Vorapaxar on Platelet Activation and Coagulation Biomarkers in Patients with Stable Coronary Artery Disease. TH Open. e259-e262.
  • Vis forfatter(e) (2018). Plasma concentrations and dietary intakes of choline and betaine in association with atrial fibrillation risk: Results from 3 prospective cohorts with different health profiles. Journal of the American Heart Association (JAHA). 11 sider.
  • Vis forfatter(e) (2018). Plasma 25-hydroxyvitamin D and mortality in patients with suspected stable angina pectoris. Journal of Clinical Endocrinology and Metabolism (JCEM). 1161-1170.
  • Vis forfatter(e) (2018). Initial Phase NT-proBNP, but Not Copeptin and High-Sensitivity Cardiac Troponin-T Yielded Diagnostic and Prognostic Information in Addition to Clinical Assessment of Out-of-Hospital Cardiac Arrest Patients With Documented Ventricular Fibrillation. Frontiers in Cardiovascular Medicine. 1-11.
  • Vis forfatter(e) (2018). Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation. International Journal of Cardiology. 7 sider.
  • Vis forfatter(e) (2018). Fibrinogen and Neopterin Is Associated with Future Myocardial Infarction and Total Mortality in Patients with Stable Coronary Artery Disease. Thrombosis and Haemostasis. 778-790.
  • Vis forfatter(e) (2018). Association of plasma neopterin with risk of an inpatient hospital diagnosis of atrial fibrillation: results from two prospective cohort studies. Journal of Internal Medicine. 578-587.
  • Vis forfatter(e) (2017). Vitamin D Uptake in Patients Treated with a High-Dosed Purified Omega-3 Compound in a Randomized Clinical Trial Following an Acute Myocardial Infarction. Frontiers in Cardiovascular Medicine. 6 sider.
  • Vis forfatter(e) (2017). The prognostic utility of dihomo-gamma-linolenic acid (DGLA) in patients with acute coronary heart disease. International Journal of Cardiology. 12-17.
  • Vis forfatter(e) (2016). Suggested Cut-Off Values for Vitamin D as a Risk Marker for Total and Cardiac Death in Patients with Suspected Acute Coronary Syndrome. Frontiers in Cardiovascular Medicine. 7 sider.
  • Vis forfatter(e) (2016). Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome. European Journal of Preventive Cardiology (EJPC). 1130-1140.
  • Vis forfatter(e) (2016). Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease . New England Journal of Medicine. 1242-1252.
  • Vis forfatter(e) (2016). Cosinor modelling of seasonal variation in 25-hydroxyvitamin D concentrations in cardiovascular patients in Norway. European Journal of Clinical Nutrition. 517-522.
  • Vis forfatter(e) (2015). Use of loop diuretics is associated with increased mortality in patients with suspected coronary artery disease, but without systolic heart failure or renal impairment: an observational study using propensity score matching. PLOS ONE. 13 sider.
  • Vis forfatter(e) (2015). Prognostic utility of vitamin D in acute coronary syndrome patients in coastal Norway. Disease Markers. 11 sider.
  • Vis forfatter(e) (2015). Glycated hemoglobin and long-term prognosis in patients with suspected stable angina pectoris without diabetes mellitus: A prospective cohort study. Atherosclerosis. 115-120.
  • Vis forfatter(e) (2015). Elevated plasma dimethylglycine is a risk marker of mortality in patients with coronary heart disease. European Journal of Preventive Cardiology (EJPC). 743-752.
  • Vis forfatter(e) (2015). Borderline values of troponin-T and high sensitivity C-reactive protein did not predict 2-year mortality inTnT positive chest-pain patients, whereas brain natriuretic peptide did. Frontiers in Cardiovascular Medicine. 1-10.
  • Vis forfatter(e) (2015). Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris. Arteriosclerosis, Thrombosis and Vascular Biology. 455-462.
  • Vis forfatter(e) (2014). New ischemic stroke and outcomes with vorapaxar versus placebo: Results from the TRA 2°P-TIMI 50 trial. Journal of the American College of Cardiology. 2318-2326.
  • Vis forfatter(e) (2014). Comparison of Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Discharged on Versus Not on Statin Therapy (from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial). American Journal of Cardiology. 1273-1279.
  • Vis forfatter(e) (2013). Vitamin D predicts all-cause and cardiac mortality in females with suspected acute coronary syndrome: a comparison with brain natriuretic peptide and high-sensitivity C-reactive protein. Cardiology Research and Practice. 8 sider.
  • Vis forfatter(e) (2013). Socioeconomic assessment and impact of social security on outcome in patients admitted with suspected coronary chest pain in the city of Salta, Argentina. Cardiology Research and Practice. 1-9.
  • Vis forfatter(e) (2013). Relationship between the intensity of heparin anticoagulation and clinical outcomes in patients receiving glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction. Catheterization and cardiovascular interventions. E9-E15.
  • Vis forfatter(e) (2013). Omega-3 index and prognosis in acute coronary chest pain patients with a low dietary intake of omega-3. Scandinavian Cardiovascular Journal. 69-79.
  • Vis forfatter(e) (2013). Long-term prognostic utility of PAPP-A and calprotectin in suspected acute coronary syndrome. Scandinavian Cardiovascular Journal. 88-97.
  • Vis forfatter(e) (2013). Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from The HORIZONS-AMI Trial). American Journal of Cardiology. 643-648.
  • Vis forfatter(e) (2013). Dietary intake of n-3 long-chain polyunsaturated fatty acids and risk of myocardial infarction in coronary artery disease patients with or without diabetes mellitus: a prospective cohort study. BMC Medicine.
  • Vis forfatter(e) (2013). Coronary Reperfusion and Clinical Outcomes After Thrombus Aspiration During Primary Percutaneous Coronary Intervention: Findings From the HORIZONS-AMI Trial. Catheterization and cardiovascular interventions. 594-601.
  • Vis forfatter(e) (2013). Cardiac resynchronization therapy improves minute ventilation/carbon dioxide production slope and skeletal muscle capillary density without reversal of skeletal muscle pathology or inflammation. Europace. 857-864.
  • Vis forfatter(e) (2012). Texture Analysis to Assess Risk of Serious Arrhythmias after Myocardial Infarction. Computers in cardiology. 365-368.
  • Vis forfatter(e) (2012). Serum 25(OH)D is a 2-year predictor of all-cause mortality, cardiac death and sudden cardiac death in chest pain patients from Northern Argentina. PLOS ONE.
  • Vis forfatter(e) (2012). Scand Cardiovasc J. 2012 Dec 12 [Epub ahead of print]. Omega-3 Index and prognosis in acute coronary chest pain patients with a low dietary intake of omega-3. Scandinavian Cardiovascular Journal.
  • Vis forfatter(e) (2012). Relationship between orthostatic hypotension and white matter hyperintensity load in older patients with mild dementia. PLOS ONE.
  • Vis forfatter(e) (2012). Omega-3 status and the relationship between plasma asymmetric dimethylarginine and risk of myocardial infarction in patients with suspected coronary artery disease. Cardiology Research and Practice. 11 sider.
  • Vis forfatter(e) (2012). Analysis of Intracardiac Electrogram Changes. Computers in cardiology. 669-672.
  • Vis forfatter(e) (2011). The heart rate of ventricular tachycardia following an old myocardial infarction is inversely related to the size of scarring. Europace. 864-868.
  • Vis forfatter(e) (2011). Low levels of the omega-3 index are associated with sudden cardiac arrest and remain stable in survivors in the subacute phase. Lipids. 151-161.
  • Vis forfatter(e) (2011). B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, Argentina. BMC Cardiovascular Disorders. 11 sider.
  • Vis forfatter(e) (2010). The activity of pregnancy-associated plasma protein A (PAPP-A) as expressed by immunohistochemistry in atherothrombotic plaques obtained by aspiration thrombectomy in patients presenting with a ST-elevation myocardial infarction: a brief communication. Thrombosis Journal.
  • Vis forfatter(e) (2010). Long- and short-term effects of tobacco smoking on circulating concentrations of B vitamins. Clinical Chemistry. 755-763.
  • Vis forfatter(e) (2010). Dietary intake of n-3 long-chain polyunsaturated fatty acids and coronary events in Norwegian patients with coronary artery disease. American Journal of Clinical Nutrition. 244-251.
  • Vis forfatter(e) (2010). Coronary blood flow and perfusion pressure during coronary angiography in patients with ongoing mechanical chest compression: a report on 6 cases. Resuscitation. 493-497.
  • Vis forfatter(e) (2010). Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. Journal of Internal Medicine. 367-382.
  • Vis forfatter(e) (2010). A history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case control study. Thrombosis Journal. 6.
  • Vis forfatter(e) (2010). A comparison of the health status after percutaneous coronary intervention at a hospital with and without on-site cardiac surgical backup: a randomized trial in nonemergent patients. European Journal of Cardiovascular Prevention & Rehabilitation. 235-243.
  • Vis forfatter(e) (2009). The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain. Thrombosis and Haemostasis. 555-563.
  • Vis forfatter(e) (2009). High Prevalence of Orthostatic Hypotension in Mild Dementia. Dementia and Geriatric Cognitive Disorders. 307-313.
  • Vis forfatter(e) (2009). Cancer incidence and mortality after treatment with folic acid and vitamin B12. Journal of the American Medical Association (JAMA). 2119-2126.
  • Vis forfatter(e) (2009). Activated factor XII type A predicts long-term mortality in patients admitted with chest pain. Journal of Thrombosis and Haemostasis. 277-287.
  • Vis forfatter(e) (2009). Activated factor XII type A and B-type natriuretic peptide are complementary and incremental predictors of mortality in patients following admission with acute coronary syndrome. Blood Coagulation and Fibrinolysis. 652-660.
  • Vis forfatter(e) (2009). (n-3) Fatty Acid Content of Red Blood Cells Does Not Predict Risk of Future Cardiovascular Events following an Acute Coronary Syndrome. Journal of Nutrition. 507-513.
  • Vis forfatter(e) (2008). The prognostic utility of D-dimer and fibrin monomer at long-term follow-up after hospitalization with coronary chest pain. Blood Coagulation and Fibrinolysis. 701-707.
  • Vis forfatter(e) (2008). The long-term prognostic value of multiple biomarkers following a myocardial infarction. Thrombosis Research. 60-66.
  • Vis forfatter(e) (2008). Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography - A Randomized controlled trial. Journal of the American Medical Association (JAMA). 795-804.
  • Vis forfatter(e) (2008). Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction. Resuscitation. 258-264.
  • Vis forfatter(e) (2008). Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction. European Journal of Clinical Nutrition. 411-418.
  • Vis forfatter(e) (2008). Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction. European Journal of Clinical Nutrition. 411-418.
  • Vis forfatter(e) (2008). Change to a primary PCI program increases number of patients offered reperfusion therapy and significantly reduces mortality. A real life experience evaluating the initiation of a primary PCI service at a single center without on site heart surgery in Western Norway. International Journal of Cardiology. 208-213.
  • Vis forfatter(e) (2008). Bivalirudin during primary PCI in acute myocardial infarction. New England Journal of Medicine. 2218-2230.
  • Vis forfatter(e) (2008). B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study. BMC Cardiovascular Disorders.
  • Vis forfatter(e) (2008). Activated Factor XII Type A Predicts Long-Term Mortality in Patients Admitted with Chest Pain. Journal of Thrombosis and Haemostasis. 277-287.
  • Vis forfatter(e) (2007). The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction. Thrombosis Research. 415-421.
  • Vis forfatter(e) (2007). Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. Journal of Internal Medicine. 244-253.
  • Vis forfatter(e) (2007). Changes of plasma activated Factor XII type A (XIIaA) concentrations following percutaneous coronary intervention (PCI). Journal of Thrombosis and Thrombolysis. 131-135.
  • Vis forfatter(e) (2007). Cardiac arrest with continuous mechanical chest compression during percutaneous coronary intervention A report on the use of the LUCAS device. Resuscitation. 454-459.
  • Vis forfatter(e) (2007). Anomalies of the coronary arteries originating from the right sinus of Valsalva (1) Single coronary artery originating from the right sinus associated with fusion of the left and the non coronary cusp and atrophy of the left coronary ostium (2)Three separate coronary arteries originating from the right sinus of Valsalva. International Journal of Cardiology. e86-e89.
  • Vis forfatter(e) (2006). Specific types of activated Factor XII increase following thrombolytic therapy with tenecteplase. Journal of Thrombosis and Thrombolysis. 199-203.
  • Vis forfatter(e) (2006). Nonemergent coronary angioplasty without on-site surgical backup: A randomized study evaluating outcomes in low-risk patients. American Heart Journal. 888-895.
  • Vis forfatter(e) (2006). Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metal loproteinase-9 following acute myocardial infarction. Thrombosis and Haemostasis. 329-336.
  • Vis forfatter(e) (2006). Late complications following the deployment of drug eluting stents. International Journal of Cardiology. 398-401.
  • Vis forfatter(e) (2006). Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials. American Heart Journal. 282-287.
  • Vis forfatter(e) (2006). Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials. American Heart Journal. 282-287.
  • Vis forfatter(e) (2005). Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. Journal of Thrombosis and Thrombolysis. 33-39.
  • Vis forfatter(e) (2005). Persistent left superior vena cava. Use of an innominate vein between left and right superior caval veins for the placement of a right ventricular lead during ICD/CRT implantation. European Heart Journal. 2178.
  • Vis forfatter(e) (2004). Clinical outcome and atherothrombogenic risk profile after prolonged wash-out following long-term treatment with high doses of n-3 PUFAs in patients with an acute myocardial infarction. Clinical Nutrition. 491-500.
  • Vis forfatter(e) (2004). Activated factor 12 (FXIIa) predicts recurrent coronary events after an acute myocardial infarction. American Heart Journal. 260-266.
  • Vis forfatter(e) (2003). Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties. Pathophysiol Haemost Thromb. 88-95.
  • Vis forfatter(e) (2003). Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following acute myocardial infarction: no effect on endothelial adhesion proteins. Pathophysiol Haemost Thromb. 88-95.
  • Vis forfatter(e) (2003). Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction. European Journal of Clinical Nutrition. 793-800.
  • Vis forfatter(e) (2003). Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction. European Journal of Clinical Nutrition. 793-800.
  • Vis forfatter(e) (2003). Changes in tissue factor and activated factor XII following an acute myocardial infarction were uninfluenced by high doses of n-3 polyunsaturated fatty acids. Thrombosis and Haemostasis. 752-759.
  • Vis forfatter(e) (2002). Characteristics and prognostic impact of plasma fibrin monomer (soluble fibrin) in patients with coronary artery disease. Blood Coagulation and Fibrinolysis. 301-308.
  • Vis forfatter(e) (2001). Reversed flow in internal mammary artery conduit and vertebral artery with left subclavian artery occlusion causing angina and vertigo. The coronary – subclavian steal syndrome. International Journal of Cardiology. 311-314.
  • Vis forfatter(e) (2001). Nytt PTCA-senter i Helseregion III. Hjerteforum. 21-22.
  • Vis forfatter(e) (2001). Effects of high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. American Journal of Clinical Nutrition. 50-56.
  • Vis forfatter(e) (2001). Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. American Journal of Clinical Nutrition. 50-56.
  • Vis forfatter(e) (2001). Beneficial changes in serum triacylglycerol and HDL-cholesterol by a high-dosed concentrate of n-3 fatty acids introduced early after an acute myocardial infarction did not improve prognosis compared to corn oil. American Journal of Clinical Nutrition. 50-56.
  • Vis forfatter(e) (2000). Plasma brain natriuretic peptide as a prognostic indicator in patients with preserved left ventricular systolic function after acute myocardial infarction. Circulation. 609.
  • Vis forfatter(e) (1999). Atherothrombogenic risk modulation by n-3 fatty acids was not associated with changes in homocysteine in subjects with combined hyperlipidaemia. Thrombosis and Haemostasis. 561-565.
  • Vis forfatter(e) (1993). Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation. British Heart Journal. 409-414.
  • Vis forfatter(e) (1993). Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with artrial natriuretic factor (99-126) and clinical evaluation. British Heart Journal. 409-414.
  • Vis forfatter(e) (1993). Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: Comparison with atrial natriuretic factor (99-126) and clinical evaluation. British Heart Journal. 409-414.
  • Vis forfatter(e) (1977). Systemic thrombin generation and activity resistant to low molecular weight heparin administered prior to streptokinase in patients with acute myocardial infarction. Thrombosis and Haemostasis. 57-61.
Vitenskapelig foredrag
  • Vis forfatter(e) (2022). Circulation 2022;146:A10315.The Effect of Protease-Activated Receptor-1 Inhibition With Vorapaxar in Post-mi and Nstemi Patients on Selected Biomarkers Reflecting Endothelial Function .
  • Vis forfatter(e) (2021). Circulation 2021 (Nov. 8); 144 (Suppl. 1): A9147. Reduced delta-6-desaturase activity may be associated with major adverse cardiac events during 2 years follow up in elderly patients with a recent myocardial infarction. .
  • Vis forfatter(e) (2020). Angiopoietin-2 is a long-term predictor of all-cause mortality, cardiac death and sudden cardiac death in chest-pain patients with suspected acute coronary syndrome.
  • Vis forfatter(e) (2018). Effects of the PAR­1 receptor antagonist vorapaxar on platelet activation and coagulation biomarkers in patients with stable coronary artery disease. EHJ 2018;39(Suppl.)50. Abstract 355.
  • Vis forfatter(e) (2016). The Prognostic Utility of Vitamin D Across Continents in Patients with Suspected Acute Coronary Syndrome. Circulation. 2016; 133: AP028.
  • Vis forfatter(e) (2015). Fibrinogen And Neopterin Predict Future Myocardial Infarction Events In Patients With Stable Coronary Heart Disease. Circulation. 2015;132:A19224.
  • Vis forfatter(e) (2013). Seasonal Discrepancy in the Correlation between Vitamin D and Omega-3 Index in Patients With Acute Coronary Syndrome from Western Norway. Circulation 2013; 128: A13208.
  • Vis forfatter(e) (2012). Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933. Epub 2012 Mar 24. Dennis W.T. Nilsen (National investigator).
  • Vis forfatter(e) (2012). Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. Dennis W.T. Nilsen (primary investigator). N Engl J Med. 2012 Jan 5;366(1):20-33. doi: 10.1056/NEJMoa1109719. Epub 2011 Nov 13.
  • Vis forfatter(e) (2012). Texture Analysis to Assess Risk of Serious Arrhythmias after Myocardial Infarction.
  • Vis forfatter(e) (2012). Circulation 2012;126:A19144(oral). New Ischemic Stroke and Outcomes with Vorapaxar vs. Placebo: Results from TRA 2°P-TIMI 50 Trial.
  • Vis forfatter(e) (2012). Circulation 2012;126:A13464(oral). Pentraxin 3 is Uninfluenced by High Doses of Concentrated Omega-3 Fatty Acids Administered for 12 Months Following an Acute Myocardial Infarction.
  • Vis forfatter(e) (2011). Vitamin D Status is a 2-Year Predictor of All-Cause Mortality and Cardiac Death in Chest Pain Patients: A Prognostic Study from Salta, Northern-Argentina. Circulation 2011; 124(21): Supplement. Abstract 10377.
  • Vis forfatter(e) (2010). Hjerteforum 2010, 23 (2): 77-80. Antitrombotisk behandling ved akutt koronarsykdom.
  • Vis forfatter(e) (2010). Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.
  • Vis forfatter(e) (2010). Circulation. 2010;122:A10837. Abstract 10837: Brain Natriuretic Peptide, but Not Calprotectin or the Long Pentraxin 3 Independently Predicts Stroke in Long-Term Follow-up of Patients With Acute Coronary Syndrome.
  • Vis forfatter(e) (2010). Activated Factor XII as a risk predictor for cardiovascular disease.
  • Vis forfatter(e) (2009). Impact of Thrombus Aspiration in Patients with STEMI Undergoing Primary PCI: Analysis from the HORIZONS-AMI Trial. Circulation, Nov 2009; 120: S986. Abstract 4690.
  • Vis forfatter(e) (2009). Impact of Thrombus Aspiration during Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: Analysis from the HORIZONS-AMI Trial. AJC 2009; 104(6) Suppl.: p 3D (Abstract 7).
  • Vis forfatter(e) (2008). Safety and effectiveness of bivalirudin compared to either abciximab or eptifibatide in patients with acute myocardial infarction undergoing primary angioplasty: The HORIZONS AMI trial. The SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit. Chicago, March 29- April 1, 2008. Abstract 2900-28.
  • Vis forfatter(e) (2008). Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: The HORIZONS AMI trial. The SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit, Chicago, March 29- April 1, 2008. Abstract 2900-192.
  • Vis forfatter(e) (2008). Identification of patients who benefit from implantable cardioverter defibrillators (ICD) by combining the genotypes for Angiotensinogen (AGT),Angiotensin-converting enzyme (ACE) and Angiotensin II type1 receptor (AT1R).Circulation 2008;118(12):e414-e491(Abstract O62, e427).
  • Vis forfatter(e) (2007). WENBIT -Western Norway B-vitamin Intervention Trial: P96, Clinical Chemistry & Laboratory Medicine. 45(5):A18, May 2007.
  • Vis forfatter(e) (2007). WENBIT - Western Norway B-vitamin intervention trial.
  • Vis forfatter(e) (2007). The prognostic value of NT-proBNP versus PAPP-A, MPO and CD40L following a myocardial infarction. European Heart Journal 2007;Vol.28 (Abstract Supplement):265: abstract 1699.
  • Vis forfatter(e) (2006). Changes In Activated Factor XII From Admission To Day 4 Strongly Predict Recurrent Troponin-T Positive Cardiac Events At 30 Days Following Admission For Myocardial InfarctionPathophysiol Haemos Thromb2006; 35:199-248.
  • Vis forfatter(e) (2006). B-Type Natriuretic peptide is a predictor of all cause mortality at long-term follow-up after hospitalization with acute chest painEur Heart J 2006, 27(Abstract Suppl), 570.
  • Vis forfatter(e) (2006). Activated Factor XII type A strongly predicts all cause mortality after hospitalisation with TnT negative chest painEur Heart J 2006, 27(Abstract Suppl), 878.
  • Vis forfatter(e) (2006). Activated Factor XII Type A Strongly Predicts All Cause Mortality after Hospitalisation with Chest Pain.AACC Annual Meeting, 2006, Chicago, Abstract nr. D52.
  • Vis forfatter(e) (2005). Activated factor XII type A strongly predicts all cause mortality after hospitalisation with TnT negative chest pain. Circulation 2005;112(17):Suppl.II:p388,abstract 1903.
  • Vis forfatter(e) (2005). Activated factor XII provides better short-term prognostic information for a subsequent troponin-T positive event than other biomarkers in patients with myocardial infarction. J Thromb Haemost 2005;3:Suppl.1, OR155. ISSN:1740-3340.
  • Vis forfatter(e) (2002). Lessons learned from the Stavanger Secondary Prevention Trial.
  • Vis forfatter(e) (2002). Background diets rich in fish may mask the effect of high doses of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on clinical, despite an improvement in lipids.
  • Vis forfatter(e) (2001). Intra-aortic balloon pump therapy in cardiology – Stabilization and transport for surgery.
  • Vis forfatter(e) (2000). Trombolysis and counterpulsation to improve cardiogenic shock survival (TACTICS) Results of a prospective randomized trial.
  • Vis forfatter(e) (2000). Trombolysis and counterpulsation to improve cardiogenic shock survival (TACTICS) Results of a prospective randomized trial.
  • Vis forfatter(e) (2000). A randomised study to evaluate the clinical efficacy of a high dosed concentrate of n-3 fatty acids introduced early after an acute myocardial infarction.
  • Vis forfatter(e) (2000). A prospective randomized trial of thrombolysis and counterpulsation to improve cardiogenic shock survival: Preliminary results of the TACTICS trial.
  • Vis forfatter(e) (2000). A prospective randomized trial of thrombolysis and counterpulsation to improve cardiogenic shock survival: Preliminary results of the TACTICS trial.
Leder
  • Vis forfatter(e) (2019). Editorial: Novel and potential markers for prediction of outcome in patients with acute and chronic coronary heart disease. Frontiers in Cardiovascular Medicine. 3 sider.
  • Vis forfatter(e) (2013). Potential Benefits of Ticagrelor beyond Platelet Inhibition. Cardiology. 31-33.
  • Vis forfatter(e) (2008). n-3 fatty acids and cardiovascular disease. Haematologica. 807-812.
Populærvitenskapelig artikkel
  • Vis forfatter(e) (2012). BestPractice. Hjerte-karsykdommer 2012;2(4):20-24. Betydningsfulle prognosemarkører hos pasienter med koronarsuspekte brystsmerter. BestPractice Hjerte-karsykdommer: Faglig dialog mellom leger. 20-24.
Kronikk
  • Vis forfatter(e) (2007). Homocysteine-lowerng trials for prevention of vascular disease: protocol for a collaborative meta-analysis. Clinical Chemistry and Laboratory Medicine. 1575-1581.
Brev til redaktøren
  • Vis forfatter(e) (2004). n-3 Fatty acids and cardiovascular disease. American Journal of Clinical Nutrition. 166.
Doktorgradsavhandling
  • Vis forfatter(e) (2022). Biomarkers related to outcome in patients with out-of-hospital cardiac arrest and in hospitalized patients with clinically suspected acute coronary syndrome. Suppl. 2.
  • Vis forfatter(e) (2017). Cardiovascular biomarkers as prognostic indicators in coronary chest pain patients.
  • Vis forfatter(e) (2016). Prognostic impact of vitamin D in coronary chest pain populations with high and low dietary intake of omega-3; comparison of a subtropical and a Nordic population.
  • Vis forfatter(e) (2013). Prognostic indicators of total-, cardiac- and sudden cardiac death in chest pain patients with suspected acute coronary syndrome (ACS); with special reference to socioeconomic class, B-type natriuretic peptide (BNP), high sensitivity C-reactive protein(hsCRP), vitamin D and the omega-3 index, https://bora.uib.no/handle/1956/6726.
  • Vis forfatter(e) (2010). The initiation and evaluation of a percutaneous coronary intervention program at a hospital without on-site cardial surgery in Western Norway.
  • Vis forfatter(e) (2010). N-3 fatty acids in relation to risk markers and clinical outcome in the acute coronary syndrome.
  • Vis forfatter(e) (2009). Studies on risk prediction in patients with chest pain and associations of the contact system to coronary heart disease, with reference to specific forms of activated Factor XII. Dissertation for the degree of philosophiae doctor (Ph.D), Institute of Medicine, Faculty of Medicine, University of Bergen, Norway, 06.11.2009.
  • Vis forfatter(e) (2009). Biomarkers for global risk assessment in the acute coronary syndrome. Dissertation for the degree of philosophiae doctor (Ph.D), University of Bergen, Norway, 27.11.2009.
  • Vis forfatter(e) (2004). Risk evaluation in atherothrombogenic populations receiving a high dose of n-3 fatty acids, with special reference to homocysteine, tissue factor, activated factor XII and peroxidation.
Sammendrag/abstract
  • Vis forfatter(e) (2013). THE LONG PENTRAXIN 3 DID NOT PREDICT OUTCOME WITHIN 45 MONTHS FOLLOW-UP IN PATIENTS FOLLOWING A SEVERE MYOCARDIAL INFARCTION. Journal of the American College of Cardiology. E185-E185.
  • Vis forfatter(e) (2012). Relationship between plasma choline and betaine levels and risk of acute myocardial infarction in patients with stable coronary heart disease. European Heart Journal. 132-132.
  • Vis forfatter(e) (2012). Plasma dimethylglycine is an independent risk factor of acute myocardial infarction in patients with stable angina pectoris. European Heart Journal. 510-510.
  • Vis forfatter(e) (2012). Long Pentraxin 3 (PTX3), Activated Factor XII type A (XIIaA) and B-type Natriuretic Peptide (BNP) did not independently predict stroke during seven years follow-up in patients admitted with chest pain. European Heart Journal. 236-236.
  • Vis forfatter(e) (2012). BNP, PTX3, and D-dimer are predictors of death, but only BNP is also a predictor of troponin-T positive cardiac events at long-term follow-up after hospitalization with acute chest pain. European Heart Journal. 947-947.
  • Vis forfatter(e) (2012). Activated factor XII type A independently predicts outcome during seven years follow-up in patients admitted with suspected acute coronary syndrome. European Heart Journal. 444-444.
  • Vis forfatter(e) (2010). Use of late gadolinium enhancement cardiovascular magnetic resonance images and texture analyses to distinguish patients with high and low risk of arrhythmias after myocardial infarction. European Heart Journal. 586-586.
  • Vis forfatter(e) (2010). A combination of novel biomarkers for coagulation (XIIaA), vascular inflammation (PTX3) and heart failure (BNP) enhances prognostic information in patients admitted with chest pain. European Heart Journal. 803-803.
  • Vis forfatter(e) (2009). Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med. 2009 May 7;360(19):1946-59. New England Journal of Medicine.
  • Vis forfatter(e) (2009). Impact of Thrombus Aspiration during Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: Analysis from the HORIZONS-AMI Trial. American Journal of Cardiology. 3D-4D.
  • Vis forfatter(e) (2009). Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial. Am Heart J. 2009 Sep;158(3):335-341.e3. American Heart Journal.
  • Vis forfatter(e) (2009). Dietary intake of very long chain n-3 fatty acids and cardiovascular events in Norwegian patients with coronary artery disease: a cohort study. European Journal of Cardiovascular Prevention & Rehabilitation. P340-P340.
  • Vis forfatter(e) (2009). Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet. 2009 Oct 3;374(9696):1149-59. Epub 2009 Aug 28. The Lancet.
  • Vis forfatter(e) (2008). The relationship between serum lipids and quartiles of the omega-3 index in a beef eating population in Argentina as compared to a fish eating ACS population in Norway. Circulation. E254-E254.
  • Vis forfatter(e) (2008). The relationship between BNP and hsCRP and quartiles of the omega-3 index in a beef eating ACS population in Argentina as compared to a coastal ACS population in Norway. Circulation. E256-E256.
  • Vis forfatter(e) (2008). Serum triglycerides may reflect the content of cellular omega-3 fatty acids in CHD populations with a low intake of fish. Circulation. E261-E261.
  • Vis forfatter(e) (2008). Intracardiac electrocardiographic (EGM) morphology changes in patients with implantable cardioverter defibrillator (ICD). Circulation. 238.
  • Vis forfatter(e) (2008). Identification of patients who benefit from implantable cardioverter defibrillators (ICD) by combining the genotypes for Angiotensinogen (AGT), Angiotensin-converting enzyme (ACE) and Angiotensin II type1 receptor (AT1R). Circulation. 427.
  • Vis forfatter(e) (2008). Comparison of the omega-3 index in the acute coronary syndromes in a beef-eating population in Argentina as compared to a fish-eating population in Norway. Circulation. E439-E439.
  • Vis forfatter(e) (2008). Activated Factor XII type A is an independent predictor of cardiovascular outcome in coronary patients admitted with troponin T negative chest pain. Circulation. E194-E195.
  • Vis forfatter(e) (2008). Activated Factor XII and B-type natriuretic peptide, but not C-reactive protein, are independent predictors of mortality following admission with suspected myocardial infarction. Circulation. E194-E194.
  • Vis forfatter(e) (2006). No prognostic value of holo-transcobalamin or methylmalonic acid following an acute myocardial infarction. Circulation. 376.
  • Vis forfatter(e) (2005). B-Type Natriuretic peptide is not only a predictor of death, but also of troponin-T positive cardiac events at 6 months follow-up after hospitalisation with acute chest pain. European Heart Journal. 717-717.
  • Vis forfatter(e) (2004). Activated factor XII predicts troponin-T positive cardiac events at 30 days follow-up after hospitalization with acute chest pain. Circulation.
Poster
  • Vis forfatter(e) (2010). Patients admitted with ST-segment elevation myocardial Infarction and a normal or near normal coronary angiogram have a favorable prognosis: Analysis from HORIZONS-AMI trial. J Am Coll Cardiol 2010;55;A187.E1746 doi:10.1016/S0735-1097(10)61747-0.
  • Vis forfatter(e) (2009). Would the use of N-terminal pro-B-type natriuretic peptide as a prognostic marker have changed our clinical judgement? Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-WE-830.
  • Vis forfatter(e) (2009). The plasma kallikrein-kinin system and clinical outcome during follow-up in chest-pain-patients. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-TH-131.
  • Vis forfatter(e) (2009). Evaluation of plaque destabilization by pregnancy-associated plasma protein a (PAPPA) and coagulant activity did not predict reccurent Troponin-T positive cardiac events following an acute myocardial infarction. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-WE-831.
  • Vis forfatter(e) (2009). Dietary intake of very long chain n-3 fatty acids and cardiovascular events in Norwegian patients with coronary artery disease: a cohort study.
  • Vis forfatter(e) (2009). Combined results and long-term follow-up in NORVIT and WENBIT with 6837 coronary artery disease patients: Homocysteine-lowering B-vitamin treatment does not prevent major cardiovascular events. European Heart Journal 2009: 30 (Abstract Supplement), 184. P 1274.
  • Vis forfatter(e) (2009). Changes of inhibitory complexes of the plasma kallikrein-kinin system following percutaneous coronary intervention or thrombolytic therapy with tenecteplase. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-WE-126.
  • Vis forfatter(e) (2009). A history of late stent thrombosis is not associated with increased activation of the contact phase system. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-MO-433.
  • Vis forfatter(e) (2008). The Prognostic Value of the Long Pentraxin 3 as Compared to B-Type Natriuretic Peptide and High-Sensitive C-Reactive Protein, and their Combination, as a Prognostic Marker of Mortality in Acute Chest Pain Patients. Circulation. 2008; 118(18): Suppl., Abstract 576.
  • Vis forfatter(e) (2008). Long Pentraxin 3: A New, Independent Marker of Mortality in Acute Chest Pain. Circulation. 2008; 118(18): Suppl., Abstract 577.
  • Vis forfatter(e) (2006). No prognostic value of holo-transcobalamin or methylmalonic acid following an acute myocardial infarction.Circulation 2006; 113: e301-e381, abstrakt nummer P325.
  • Vis forfatter(e) (2006). No effect of omega-3 versus corn oil intervention on Pregnancy-Associated Plasma Protein A (PAPP-A) and CD-40 Ligand following an acute myocardial infarction.Circulation 2006; 113: e301-e381, abstrakt nummer P315.
  • Vis forfatter(e) (2006). No Protection of a High Omega-3 Index Following an Acute Myocardial Infarction.Atherosclerosis 2006; 7 (3): Suppl. pp 449.
  • Vis forfatter(e) (2000). Influence on inflammatory markers of high-dose n-3 fatty acids after one year of treatment following an acute myocardial infarction.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2012). The Role of Long-Chained Marine N-3 Polyunsaturated Fatty Acids in Cardiovascular Disease. Cardiology Research and Practice. 15 sider.

Se fullstendig oversikt over publikasjoner i CRIStin.

Forskergrupper